Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;53(9):865-73.
doi: 10.1177/0009922814533592. Epub 2014 May 9.

Payment analysis of two diagnosis and management approaches of acute otitis media

Janet R Casey  1 , Michael E Pichichero  2
Affiliations

Payment analysis of two diagnosis and management approaches of acute otitis media

Janet R Casey et al. Clin Pediatr (Phila). 2014 Aug.

Abstract

We determined the cost of care for 2 diagnosis and management approaches for acute otitis media (AOM) among children 6 to 30 months old. A case-control design was used. Cases included 208 children diagnosed with AOM based on a bulging tympanic membrane (TM) and treated with amoxicillin/clavulanate. Controls (5:1 ratio) included 1020 children with AOM diagnosed not requiring bulging of the TM and treated with amoxicillin. Fewer cases (49%) than controls (69%) were diagnosed with AOM (P < .001), fewer were diagnosed with recurrent AOM or AOM treatment failure (0.34 vs 1.6/child; P < .0001), and fewer had insertion of tympanostomy tubes (6.3% vs 14.8%) due to recurrent AOM (P < .0001). The combined direct payments and indirect costs for management of AOM were $539/case versus $1,023/control. Using Rochester NY payments generalized to the US birth cohort, this case diagnosis and treatment strategy could save $1.008 billion per year.

Keywords: acute otitis media; antibiotics; guidelines; payment analysis; tympanostomy tubes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

  • Vaccine targets against Moraxella catarrhalis.
    Ren D, Pichichero ME. Ren D, et al. Expert Opin Ther Targets. 2016;20(1):19-33. doi: 10.1517/14728222.2015.1081686. Epub 2015 Aug 26. Expert Opin Ther Targets. 2016. PMID: 26565427 Free PMC article. Review.
  • Ten-Year Study of the Stringently Defined Otitis-prone Child in Rochester, NY.
    Pichichero ME. Pichichero ME. Pediatr Infect Dis J. 2016 Sep;35(9):1033-9. doi: 10.1097/INF.0000000000001217. Pediatr Infect Dis J. 2016. PMID: 27273691 Free PMC article. Review.
  • A2ML1 and otitis media: novel variants, differential expression, and relevant pathways.
    Larson ED, Magno JPM, Steritz MJ, Llanes EGDV, Cardwell J, Pedro M, Roberts TB, Einarsdottir E, Rosanes RAQ, Greenlee C, Santos RAP, Yousaf A, Streubel SO, Santos ATR, Ruiz AG, Lagrana-Villagracia SM, Ray D, Yarza TKL, Scholes MA, Anderson CB, Acharya A; University of Washington Center for Mendelian Genomics; Gubbels SP, Bamshad MJ, Cass SP, Lee NR, Shaikh RS, Nickerson DA, Mohlke KL, Prager JD, Cruz TLG, Yoon PJ, Abes GT, Schwartz DA, Chan AL, Wine TM, Cutiongco-de la Paz EM, Friedman N, Kechris K, Kere J, Leal SM, Yang IV, Patel JA, Tantoco MLC, Riazuddin S, Chan KH, Mattila PS, Reyes-Quintos MRT, Ahmed ZM, Jenkins HA, Chonmaitree T, Hafrén L, Chiong CM, Santos-Cortez RLP. Larson ED, et al. Hum Mutat. 2019 Aug;40(8):1156-1171. doi: 10.1002/humu.23769. Epub 2019 May 21. Hum Mutat. 2019. PMID: 31009165 Free PMC article.
  • Rare A2ML1 variants confer susceptibility to otitis media.
    Santos-Cortez RL, Chiong CM, Reyes-Quintos MR, Tantoco ML, Wang X, Acharya A, Abbe I, Giese AP, Smith JD, Allen EK, Li B, Cutiongco-de la Paz EM, Garcia MC, Llanes EG, Labra PJ, Gloria-Cruz TL, Chan AL, Wang GT, Daly KA, Shendure J, Bamshad MJ, Nickerson DA, Patel JA, Riazuddin S, Sale MM; University of Washington Center for Mendelian Genomics; Chonmaitree T, Ahmed ZM, Abes GT, Leal SM. Santos-Cortez RL, et al. Nat Genet. 2015 Aug;47(8):917-20. doi: 10.1038/ng.3347. Epub 2015 Jun 29. Nat Genet. 2015. PMID: 26121085 Free PMC article.
  • Genetic and Environmental Determinants of Otitis Media in an Indigenous Filipino Population.
    Santos-Cortez RL, Reyes-Quintos MR, Tantoco ML, Abbe I, Llanes EG, Ajami NJ, Hutchinson DS, Petrosino JF, Padilla CD, Villarta RL Jr, Gloria-Cruz TL, Chan AL, Cutiongco-de la Paz EM, Chiong CM, Leal SM, Abes GT. Santos-Cortez RL, et al. Otolaryngol Head Neck Surg. 2016 Nov;155(5):856-862. doi: 10.1177/0194599816661703. Epub 2016 Aug 2. Otolaryngol Head Neck Surg. 2016. PMID: 27484237 Free PMC article.
See all "Cited by" articles

References

    1. Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort. Pediatrics. 2000;105:1–7. - PubMed
    1. O’Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009;123:1452–1463. - PubMed
    1. Subcommittee on Management of Acute Otitis Media. Diagnosis and Management of Acute Otitis Media. Pediatrics. 2004;113:1451–1465. - PubMed
    1. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, Joffe MD, Miller DT, Rosenfeld RM, Sevilla XD, Schwartz RH, Thomas PA, Tunkel DE. Diagnosis and Management of Acute Otitis Media. Pediatrics. 2013;131:e964–e999. - PubMed
    1. Pichichero ME, Casey JR. Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children. JAMA. 2007;298(15):1772–1778. - PubMed

Publication types

Substances